Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.8860 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Eric L Simpson und 12 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Pruritus, Antipruritics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Simpson, E. L., Silverberg, J. I., Bissonnette, R., Stein Gold, L., Armstrong, A., Hebert, A. A., Serrao, R. T., Jakus, J. R., Brown, P. M., Rubenstein, D. S., Piscitelli, S. C., Tallman, A. M., & Eichenfield, L. F. (2025). Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8860
Vancouver
Simpson EL, Silverberg JI, Bissonnette R, Stein Gold L, Armstrong A, Hebert AA, et al. Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8860
BibTeX
@article{Simpson2025,
author = {Simpson, Eric L and Silverberg, Jonathan I and Bissonnette, Robert and Stein Gold, Linda and Armstrong, April and Hebert, Adelaide A and Serrao, Rocco T and Jakus, Jeannette R and Brown, Philip M and Rubenstein, David S and Piscitelli, Stephen C and Tallman, Anna M and Eichenfield, Lawrence F},
title = {Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.8860}
}
EUVIMED